Contracts and kill switches: the business of reprocessing
advertisement
Current Location:
>
> This Story

starstarstarstarstar (2)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

More Magazine Features

The value of ISOs in an era of personalization and consolidation The unique value proposition of high quality third-party service

What to look for in an OEM service contract Communication the unique needs of your facility is key to getting the right coverage

The road ahead for breast density awareness It's been a good year for advocacy, here's what happens next

OB/GYN ultrasound: is the field ready to adopt new technology in the market? What do new capabilities mean for creatures of habit?

Breast imaging advances with new AI, MR and ultrasound solutions A look at innovative new technology entering the market

See All Magazine Features  

Medical Devices Homepage

Le Bonheur Children's Hospital first to install Triux neo MEG system Assesses neurological conditions with functional brain imaging

Philips new MR dramatically cuts helium requirement and needs no vent pipe The Ingenia Ambition X 1.5T MR features a fully-sealed magnet

Paurvi Bhatt Medtronic appoints president of Medtronic Foundation

GE Healthcare joins AdvaMed Access to global thought leadership and policy area expertise

Envoy Medical hearing implant gets FDA green light for MR-conditional labeling Approved for both 1.5 and 3.0 Tesla scanners

NIH grants $1.5 million to Magnetic Insight for development of new imaging modality Uses non-radioactive, iron oxide nanoparticle tracer

FDA clears lymph node biopsy system for metastatic breast cancer detection Requires no radioactive and blue dye injections

House votes to repeal medical device tax One step closer to eliminating 2.3 percent fee on sales

Onkos Surgical and Insight Medical partner to bring augmented reality to tumor surgery Could this become the new standard of care?

New research finds leadless pacemakers cause fewer complications than conventional option Will they become the new standard?

Contracts and kill switches: the business of reprocessing

by Lisa Chamoff , Contributing Reporter
From the January 2015 issue of DOTmed HealthCare Business News magazine



Kill switches
Many in the reprocessing industry say that OEMs are modifying their products so they cannot be reprocessed, by adding a chip, rendering the product ineffective if it’s reprocessed, or modifying the device — for example, changing the curvature of a scalpel — so that it doesn’t have 510(k) approval from the FDA for reprocessing.
Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.




Craig Allmendinger, founder and chief executive officer of NEScientific, says he has seen these “kill switches” in the cardiovascular devices that his firm is preparing for 510(k) submissions.

“Those are technologies we have overcome and we still have to overcome,” Allmendinger says.

Janet Graesser director of global communications for Johnson & Johnson, responded to suggestions by industry sources that after acquiring SterilMed, Johnson & Johnson has been building chips into single-use devices that prevent them from being reprocessed by a third-party, as well as working language into contracts with hospitals that discourages reprocessing.

“Some medical devices manufactured by Johnson & Johnson operating companies include advanced components that enhance the performance of such medical devices,” Graesser said. “SterilMed, Inc., part of the Johnson & Johnson family of companies, collaborates with some of its sister operating companies to offer unique solutions that support the economic and environmental sustainability goals of its customers, including offering high-quality reprocessed medical devices to their customers.”

Industry changes
While OEM campaigns aimed at curtailing reprocessing are nothing new, some of the consolidation within the industry has raised eyebrows — and suspicions.

In 2010 Stryker, which was a critic of reprocessing, acquired Ascent Healthcare Solutions and renamed it Stryker Sustainability Solutions. In 2011, Ethicon Endo-Surgery, a division of Johnson & Johnson with a well documented history of anti-reprocessing tactics, acquired SterilMed, the second-largest reprocessing company in the U.S.

The acquisitions left industry veterans wondering if the companies, which account for 95 percent of the market, would grow the reprocessing businesses or fragment them to protect sales.

Daniel Vukelich, president of the Association of Medical Device Reprocessors, says SterilMed was a founding member of the industry organization, but left after its acquisition by Johnson & Johnson, and only Stryker Sustainability Solutions, Vanguard, and Medline ReNewal, which was brought into the fold last year, remain in the group.

<< Pages: 1 - 2 - 3 - 4 - 5 >>

Medical Devices Homepage


You Must Be Logged In To Post A Comment